Methods for preventing and treating peripheral neuropathy by administering desmethylselegiline delivery compositions
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
N/A
app pub date -
Mar 4, 2003
filing date -
Jul 31, 1995
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
The present disclosure is directed to methods for alleviating the symptoms associated with peripheral neuropathy by administering R(-)-desmethylselegiline, S(+) desmethylselegiline, or a combination of the two. The neuropathy may be the result of a genetically inherited condition, a systemic disease, or exposure to a toxic agent. The disclosure is also directed to a method for treating patients with cancer by administering a chemotherapeutic agent known to have a toxic affect on peripheral nerves together with R(-)-desmethylselegiline, S(+) desmethylselegiline, or a mixture of the two.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully